{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T09:44:34Z","timestamp":1700214274454},"reference-count":27,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.8663","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T10:27:56Z","timestamp":1519900076000},"source":"Crossref","is-referenced-by-count":4,"title":["miR\u2011367 enhances the proliferation and invasion of cutaneous malignant melanoma by regulating phosphatase and tensin homolog expression"],"prefix":"10.3892","author":[{"given":"Jianwen","family":"Long","sequence":"first","affiliation":[{"name":"Department of Dermatology, The First Clinical School, Hubei University of Chinese Medicine, Wuhan, Hubei 430061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuwen","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, Hubei 430061, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"key20200713225002_b1-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"E110","DOI":"10.3390\/cancers8120110","article-title":"Biology, therapy and implications of tumor exosomes in the progression of melanoma","volume":"8","author":"Isola","year":"2016","journal-title":"Cancers"},{"key":"key20200713225002_b2-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bjps.2006.05.008","article-title":"Incidence, mortality and survival in cutaneous melanoma","volume":"60","author":"Giblin","year":"2007","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"key20200713225002_b3-mmr-17-05-6526","first-page":"196","article-title":"Incidence, survival and mortality of malignant Cutaneous melanoma in Wisconsin, 1995\u20132011","volume":"114","author":"Peterson","year":"2015","journal-title":"WMJ"},{"key":"key20200713225002_b4-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.bjc.6603216","article-title":"Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993\u20132003","volume":"95","author":"Downing","year":"2006","journal-title":"Br J Cancer"},{"key":"key20200713225002_b5-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jso.20079","article-title":"The natural course of cutaneous melanoma","volume":"86","author":"Leiter","year":"2004","journal-title":"J Surg Oncol"},{"key":"key20200713225002_b6-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ejcb.2014.02.001","article-title":"The role of microRNAs in melanoma","volume":"93","author":"Luo","year":"2014","journal-title":"Eur J Cell Biol"},{"key":"key20200713225002_b7-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/bjd.12493","article-title":"Molecular markers in melanoma","volume":"170","author":"Kashani-Sabet","year":"2014","journal-title":"Br J Dermatol"},{"key":"key20200713225002_b8-mmr-17-05-6526","unstructured":"MannucciCCasciaroMMinciulloPLCalapaiGNavarraMGangemiSInvolvement of microRNAs in skin disorders: A literature reviewAllergy Asthma Proc38915201710.2500\/aap.2017.38.401328052797"},{"key":"key20200713225002_b9-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"5246","DOI":"10.2174\/1381612820666140128210105","article-title":"MicroRNAs in cancer: Lessons from melanoma","volume":"20","author":"Greenberg","year":"2014","journal-title":"Curr Pharm Des"},{"key":"key20200713225002_b10-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gde.2006.02.012","article-title":"Gene regulation by microRNAs","volume":"16","author":"Carthew","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"key20200713225002_b11-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ceb.2004.02.006","article-title":"Expanding roles for miRNAs and siRNAs in cell regulation","volume":"16","author":"Nakahara","year":"2004","journal-title":"Curr Opin Cell Biol"},{"key":"key20200713225002_b12-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"9032502","DOI":"10.1155\/2017\/9032502","article-title":"miR-219-5p inhibits the growth and metastasis of malignant melanoma by targeting BCL-2","volume":"2017","author":"Long","year":"2017","journal-title":"Biomed Res Int"},{"key":"key20200713225002_b13-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"e2706","DOI":"10.7717\/peerj.2706","article-title":"MicroRNA biogenesis pathway genes polymorphisms and cancer risk: A systematic review and meta-analysis","volume":"4","author":"He","year":"2016","journal-title":"Peer J"},{"key":"key20200713225002_b14-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"22262","DOI":"10.18632\/oncotarget.14763","article-title":"MicroRNAs in melanoma development and resistance to target therapy","volume":"8","author":"Fattore","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713225002_b15-mmr-17-05-6526","first-page":"2881","article-title":"Loss of PTEN promotes tumor development in malignant melanoma","volume":"63","author":"Stahl","year":"2003","journal-title":"Cancer Res"},{"key":"key20200713225002_b16-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"BSR20170837","DOI":"10.1042\/BSR20170837","article-title":"Up-regulated microRNA-500a enhances hepatocarcinoma metastasis by repressing PTEN expression","volume":"37","author":"Zhao","year":"2017","journal-title":"Biosci Rep"},{"key":"key20200713225002_b17-mmr-17-05-6526","first-page":"6895","article-title":"miR-20b promotes cellular proliferation and migration by directly regulating phosphatase and tensin homolog in prostate cancer","volume":"14","author":"Guo","year":"2017","journal-title":"Oncol Lett"},{"key":"key20200713225002_b18-mmr-17-05-6526","first-page":"6576","article-title":"High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma","volume":"8","author":"Guan","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20200713225002_b19-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbrc.2016.01.042","article-title":"MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma","volume":"473","author":"Sun","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713225002_b20-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3892\/or.2016.5314","article-title":"miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7","volume":"37","author":"Xu","year":"2017","journal-title":"Oncol Rep"},{"key":"key20200713225002_b21-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/gtmb.2014.0210","article-title":"The microRNA-367 inhibits the invasion and metastasis of gastric cancer by directly repressing Rab23","volume":"19","author":"Bin","year":"2015","journal-title":"Genet Test Mol Biomarkers"},{"key":"key20200713225002_b22-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1183\/09031936.00048712","article-title":"Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer","volume":"41","author":"Campayo","year":"2013","journal-title":"Eur Respir J"},{"key":"key20200713225002_b23-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/cas.12733","article-title":"miR-367 promotes proliferation and stem-like traits in medulloblastoma cells","volume":"106","author":"Kaid","year":"2015","journal-title":"Cancer Sci"},{"key":"key20200713225002_b24-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fonc.2015.00024","article-title":"PTEN: Multiple functions in human malignant tumors","volume":"5","author":"Milella","year":"2015","journal-title":"Front Oncol"},{"key":"key20200713225002_b25-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1038\/onc.2016.526","article-title":"Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma","volume":"36","author":"Yang","year":"2017","journal-title":"Oncogene"},{"key":"key20200713225002_b26-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"Song","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20200713225002_b27-mmr-17-05-6526","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/156800908784293659","article-title":"The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications","volume":"8","author":"Carnero","year":"2008","journal-title":"Curr Cancer Drug Targets"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T22:57:22Z","timestamp":1594681042000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.8663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":27,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.8663","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]}}}